Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

Market Cap	4.38B +3.8%
Revenue (ttm)	1.08B +4.6%
Net Income	184.79M +185.2%
EPS	0.46 +185.3%
Shares Out	401.74M
PE Ratio	23.55
Forward PE	n/a
Dividend	0.08 (0.75%)
Ex-Dividend Date	Jun 17, 2026

Volume	43,220,376
Open	12.09
Previous Close	11.81
Day's Range	10.91 - 12.09
52-Week Range	8.58 - 13.56
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:300434

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, and health food/health supplements, as well as Chinese herbal active pharmaceutical ingredients and food addictives, and medical devices. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company pr...

• Industry: Industrial Distribution
• Sector: Industrials
• Founded: 1962
• Employees: 1,794
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300434

Financial Performance

In 2025, SHE:300434's revenue was 1.04 billion, a decrease of -5.80% compared to the previous year's 1.10 billion. Earnings were 131.62 million, an increase of 43.44%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 17, 2026

Data Sources Report a data error